Avalo Therapeutics
AVTX
AVTX
9 hedge funds and large institutions have $2.37M invested in Avalo Therapeutics in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AC
Armistice Capital
New York
|
+$1.94M |
2 |
Bank of New York Mellon
New York
|
+$14K |
3 |
Citadel Advisors
Miami,
Florida
|
+$10K |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.7K |
Top Sellers
1 |
UBS Group
Zurich,
Switzerland
|
-$9K |
2 |
VKH
Virtu KCG Holdings
New York
|
-$1.64K |